J Cancer 2024; 15(8):2276-2291. doi:10.7150/jca.90170 This issue Cite

Research Paper

DOT1L promotes expression of CD44 through the Wnt/β-catenin signaling pathway in early gastric carcinoma

Ping Li1,2,3*, Zhou Zhang4*, Ping Sun1,2,3✉

1. Department of Pathology, Jiangnan University Medical Center, Wuxi, Jiangsu Province 214002, PR China.
2. Department of Pathology, Wuxi No.2 People's Hospital, Wuxi, Jiangsu Province 214002, PR China.
3. Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu Province 214002, PR China.
4. Department of Clinical Laboratory, Affiliated Huishan Hospital of Xinglin College, Nantong University, Wuxi Huishan District People's Hospital, Wuxi, Jiangsu Province 214000, PR China.
*First author: Ping Li and Zhou Zhang.

Citation:
Li P, Zhang Z, Sun P. DOT1L promotes expression of CD44 through the Wnt/β-catenin signaling pathway in early gastric carcinoma. J Cancer 2024; 15(8):2276-2291. doi:10.7150/jca.90170. https://www.jcancer.org/v15p2276.htm
Other styles

File import instruction

Abstract

Graphic abstract

To assess telomere silencing 1-like (DOTIL) gene expression within gastric cancer (GC) tissues as well as its function of promoting cancer stem cell (CSC)-mediated epithelial-mesenchymal switching, tissue samples from 8 patients each in 3 stages (normal, low-grade intraepithelial neoplasia (LGIN), as well as early gastric carcinoma (EGC)) were collected for whole-exome sequencing, which revealed differentially expressed genes (DEGs). The DEGs and their prognostic value were verified through TCGA and GTEx analyses. We also verified the role of DOT1L in EGC development. We collected samples from three patients each with LGIN and EGC for single-cell sequencing. We conducted single-cell transcriptomic analysis, DEG analysis, cell‒cell interaction analysis, and pseudotime analysis using R language. Sites and levels of DOT1L, CD44 and DOT1L expression were verified by IF. We found 703 deleterious mutation sites in the LGIN group and 389 deleterious mutation sites in the EGC group. The LGIN as well as EGC categories exhibited increased levels of DOT1L expression compared to the standard category (P<0.05) in TCGA and GTEx. DOT1L also correlated significantly with TMB (P=8.45E-06), MSI (P=0.001), and tumor proliferation index (P=7.17E-09) in the TCGA and GTEx datasets. In single cells, we found that DOT1L promotes CD44 expression via the Wnt/β-catenin signaling pathway and the development for stemness properties within GC. In addition, we found that DOT1L, CD44 and CTNNB1 colocalize and correlate positively. In conclusion, one important CSC regulator in GC, DOT1L may be crucial in coordinating the expression of genes specific to a certain lineage during MSC development.

Keywords: DOT1L, CD44, Wnt/β-catenin, early gastric carcinoma


Citation styles

APA
Li, P., Zhang, Z., Sun, P. (2024). DOT1L promotes expression of CD44 through the Wnt/β-catenin signaling pathway in early gastric carcinoma. Journal of Cancer, 15(8), 2276-2291. https://doi.org/10.7150/jca.90170.

ACS
Li, P.; Zhang, Z.; Sun, P. DOT1L promotes expression of CD44 through the Wnt/β-catenin signaling pathway in early gastric carcinoma. J. Cancer 2024, 15 (8), 2276-2291. DOI: 10.7150/jca.90170.

NLM
Li P, Zhang Z, Sun P. DOT1L promotes expression of CD44 through the Wnt/β-catenin signaling pathway in early gastric carcinoma. J Cancer 2024; 15(8):2276-2291. doi:10.7150/jca.90170. https://www.jcancer.org/v15p2276.htm

CSE
Li P, Zhang Z, Sun P. 2024. DOT1L promotes expression of CD44 through the Wnt/β-catenin signaling pathway in early gastric carcinoma. J Cancer. 15(8):2276-2291.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image